D020748Chemicals & DrugsD02.455.426.559.847.638.960.585D03.633.100.103.618D04.615.638.960.585240.996006Mibefradilprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson10991994Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DAThe Journal of pharmacology and experimental therapeuticsMibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther. 2000 Oct; 295(1):302-8.J Pharmacol Exp Ther2000-10-01T00:00:002000Mibefradil block of cloned T-type calcium channels.11358939Griffin KA, Picken M, Bakris GL, Bidani AKHypertension (Dallas, Tex. : 1979)Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model. Hypertension. 2001 May; 37(5):1268-72.Hypertension2001-05-01T00:00:002001Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.15562257McNulty MM, Hanck DAMolecular pharmacologyState-dependent mibefradil block of Na+ channels. Mol Pharmacol. 2004 12; 66(6):1652-61.Mol Pharmacol2004-12-01T00:00:002004State-dependent mibefradil block of Na+ channels.16885209McNulty MM, Kyle JW, Lipkind GM, Hanck DAMolecular pharmacologyAn inner pore residue (Asn406) in the Nav1.5 channel controls slow inactivation and enhances mibefradil block to T-type Ca2+ channel levels. Mol Pharmacol. 2006 Nov; 70(5):1514-23.Mol Pharmacol2006-08-02T00:00:002006An inner pore residue (Asn406) in the Nav1.5 channel controls slow inactivation and enhances mibefradil block to T-type Ca2+ channel levels.0.7495030.05088792research area of0.2941520.1963094subject area forUniversity of ChicagoGeorgeBakris0GBoa7McCszMknJtY0fp/Cv/+94=George Bakris41.78927490000000-87.601250000000001393Bakris, GeorgeProfessorDorothyHanckDorothy Hanck41.78927490000000-87.601250000000002657Hanck, DorothyEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessorMedicine-CardiologyMedicine-Endocrinology